# To Evaluate the Safety and Efficacy of Pediococcus Acidilactici PA53 in Relieving Constipation in Adults

> **NCT06761443** · NA · RECRUITING · sponsor: **Wecare Probiotics Co., Ltd.** · enrollment: 10 (estimated)

## Conditions studied

- Constipation

## Interventions

- **DIETARY_SUPPLEMENT:** Probiotic
- **DIETARY_SUPPLEMENT:** Maltodextrin

## Key facts

- **NCT ID:** NCT06761443
- **Lead sponsor:** Wecare Probiotics Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-02-25
- **Primary completion:** 2025-04-25
- **Final completion:** 2025-05-25
- **Target enrollment:** 10 (ESTIMATED)
- **Last updated:** 2025-01-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06761443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06761443, "To Evaluate the Safety and Efficacy of Pediococcus Acidilactici PA53 in Relieving Constipation in Adults". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT06761443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*